Fanconi syndrome and lactic acidosis associated with stavudine and lamivudine therapy

AIDS

Volumn 22, Issue 11, 2008, Pages 1374-1376

  Nelson, Mark ^a   Azwa, Alex ^a   Sokwala, Ahmed ^b   Harania, Reena Shah ^b   Stebbing, Justin ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b AGA KHAN UNIVERSITY   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; LAMIVUDINE; NEVIRAPINE; NUCLEOSIDE; STAVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; DYSPNEA; FANCONI RENOTUBULAR SYNDROME; FEMALE; FLUID THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOKALEMIA; HYPOPHOSPHATEMIA; KIDNEY TUBULE CELL; LABORATORY TEST; LACTIC ACIDOSIS; MITOCHONDRIAL TOXICITY; PATHOGENESIS; PRIORITY JOURNAL; WEAKNESS; CHEMICALLY INDUCED DISORDER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;

ACIDOSIS, LACTIC; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FANCONI SYNDROME; FEMALE; HIV INFECTIONS; HUMANS; LAMIVUDINE; REVERSE TRANSCRIPTASE INHIBITORS; STAVUDINE;

EID: 49849090481     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328303be50     Document Type: Article

References (16)

1. Gupta SK. Tenofovir-associated Fanconi syndrome: review of the FDA adverse event reporting system. AIDS Patient Care STDS 2008; 22:99-103.
2. Morris AAM, Baudouin SV, Snow MH. Renal tubular acidosis and hypophosphataemia after treatment with nucleoside reverse transcriptase inhibitors. AIDS 2001; 15:140-141.
3. Ogedegbe A, Thomas D, Diehl A. Hyperlactataemiasyndromes associated with HIV therapy. Lancet Infect Dis 2003; 3:329-337.
4. Birkus G, Hitchcock JMH, Cihlar T. Assessment of mitochon-drial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors. Antimi-crob Agents Chemother 2002; 46:716-723.
5. Moyle GJ, Datta D, Mandhalia S, MorleseJ, Asboe D, Gazzard BG. Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors. AIDS 2002; 16:1341-1346.
6. Bonnet F, Bonarek M, Morlat P, et al. Risk factors for lactic acidosis in HIV-infected patients treated with nucleoside reverse transcriptase inhibitors: a case-control study. Clin Infec Dis 2003; 36:1324-1328.
7. Brinkman K, ter Hofstede HJM, Burger DM, et al. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS 1998; 12:1735-1744.
8. Falco V, Rodriguez D, Ribera E, et al. Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literature. Clin Infect Dis 2002; 34:838-846.
9. Quimby D, Brito MO. Fanconi syndrome associated with use of tenofovir in HIV-infected patients: a case report and review of the literature. AIDS Read 2005; 15:357-364.
10. Malik A, Abraham P, Malik N. Acute renal failure and Fanconi syndrome in an AIDS patient on tenofovir treatment: case report and review of literature. J Infect 2005; 51:E61-E65.
11. Matthew G, Knaus SJ. Acquired Fanconi's syndrome associated with tenofovir therapy. J Gen Int Med 2006; 21 :C3-C5.
12. Vittecoq D, Dumitrescu L, Beaufils H, Deray G. Fanconi syndrome associated with cidofovir therapy. Antimicrob Agents Chemother 1997; 41:1846.
13. IzzedineH, Launay-Vacher V, Deray G. Antiviral drug-induced nephrotoxicity. Am J Kidney Dis 2005; 45:804-817.
14. Ahmad M. Abacavir-induced reversible Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome. J Postgrad Med 2006; 52:296-297.
15. D'Ythurbide G, Goujard C, Mechai F, Blanc A, Charpentier B, Snanoudj R. Fanconi syndrome and nephrogenic diabetes insipidus associated with didanosine therapy in HIV infection: a case report and literature review. Nephrol Dial Transplant 2007; 22:3656-3659.
16. Ho ES, Lin DC, Mendel DB, Cihlar T. Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. J Am Soc Nephrol 2000; 11:383-393.